SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Drug Development
TG Therapeutics, Inc. Launches Phase I/II “Triple-Therapy” Study With TGR-1202 + TG-1101 + The PD-1 Checkpoint Inhibitor Pembrolizumab In Patients With Advanced Chronic Lymphocytic Leukemia (CLL) At The University of Pennsylvania’s Abramson Cancer Center
September 9, 2015
 · 
5 min read
Business
TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results And Business Update
August 10, 2015
 · 
10 min read
Business
TG Therapeutics, Inc. To Host Conference Call On Second Quarter 2015 Financial Results And Business Update
August 5, 2015
 · 
1 min read
Drug Development
TG Therapeutics, Inc. Release: Updated Results From Phase II Clinical Trial Of TG-1101 (Ublituximab) In Combination With Ibrutinib Confirms Robust Clinical Activity With A Favorable Safety Profile In Patients With Previously Treated, High-Risk Chronic Lym
June 18, 2015
 · 
8 min read
Drug Development
TG Therapeutics, Inc. To Present Clinical Data On TG-1101 And TGR-1202 At The 20th Congress Of The European Hematology Association And The 13th International Congress On Malignant Lymphoma
June 12, 2015
 · 
5 min read
Pharm Country
TG Therapeutics, Inc. To Present At The Jefferies and Co. 2015 Healthcare Conference
June 2, 2015
 · 
1 min read
Drug Development
ASCO15: TG Therapeutics, Inc. Announces The Triple Combination Of TG-1101, TGR-1202 And Ibrutinib Is Safe And Highly Active In Patients With Advanced B-Cell Malignancies
June 1, 2015
 · 
9 min read
Drug Development
ASCO15: TG Therapeutics, Inc. Announces Presentations Of Its Proprietary Combination Of TG-1101 Plus TGR-1202 As Well As TGR-1202 As A Single Agent In Ongoing Phase I/Ib Dose Escalation Clinical Studies
June 1, 2015
 · 
13 min read
Pharm Country
ASCO15: TG Therapeutics, Inc. Recaps Schedule Of Clinical Data Presentations At The 51st Annual Meeting Of The ASCO
May 29, 2015
 · 
5 min read
Pharm Country
TG Therapeutics, Inc. Announces Clinical Data Presentations At The Upcoming 51st Annual Meeting Of The ASCO
May 14, 2015
 · 
4 min read
Business
TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results And Business Update
May 4, 2015
 · 
8 min read
Pharm Country
TG Therapeutics, Inc. To Present At The Deutsche Bank 40th Annual Health Care Conference
May 1, 2015
 · 
1 min read
Business
TG Therapeutics, Inc. To Host Conference Call On First Quarter 2015 Financial Results And Business Update
April 30, 2015
 · 
1 min read
Drug Development
Ligand Pharmaceuticals Inc. Partner TG Therapeutics, Inc. Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting
April 20, 2015
 · 
6 min read
Drug Development
TG Therapeutics, Inc. Presents Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting
April 20, 2015
 · 
4 min read
Business
TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2014 Financial Results And Business Update
March 12, 2015
 · 
11 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS